tiprankstipranks
Advertisement
Advertisement

CNTB Stock Latest News

Connect Biopharma initiated with a Buy at Canaccord
The FlyConnect Biopharma initiated with a Buy at Canaccord
21d ago
CNTB
Connect Biopharma initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Connect Biopharma initiated with an Overweight at Cantor Fitzgerald
26d ago
CNTB
Connect Biopharma initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Connect Biopharma initiated with an Overweight at Cantor Fitzgerald
26d ago
CNTB
Connect Biopharma files to sell 6.13M ordinary shares for holders
PremiumThe Fly
Connect Biopharma files to sell 6.13M ordinary shares for holders
1M ago
CNTB
Analyst Reiterates Buy on Rademikibart, Citing Strong Clinical Profile, Large Market Opportunity and Unchanged $10 Price Target
PremiumRatings
Analyst Reiterates Buy on Rademikibart, Citing Strong Clinical Profile, Large Market Opportunity and Unchanged $10 Price Target
1M ago
CNTB
Connect Biopharma reports Q1 EPS (34c), consensus (28c)
PremiumThe FlyConnect Biopharma reports Q1 EPS (34c), consensus (28c)
1M ago
CNTB
Connect Biopharma Advances Rademikibart After Positive Interim Review
Premium
Company Announcements
Connect Biopharma Advances Rademikibart After Positive Interim Review
2M ago
8K
CNTB
Connect Biopharma announces enrollment in Seabreeze STAT study
Premium
The Fly
Connect Biopharma announces enrollment in Seabreeze STAT study
2M ago
CNTB
Connect Biopharma director buys $4.0M in common stock
PremiumThe Fly
Connect Biopharma director buys $4.0M in common stock
3M ago
CNTB
Buy Rating on CNTB Driven by Rademikibart’s Rapid Lung Function Gains, COPD Differentiation, and Strengthened Cash Runway
PremiumRatings
Buy Rating on CNTB Driven by Rademikibart’s Rapid Lung Function Gains, COPD Differentiation, and Strengthened Cash Runway
3M ago
CNTB
Buy Rating on CNTB: Fast-Acting Rademikibart Data Underscore Differentiation and Long-Term Respiratory Opportunity
PremiumRatings
Buy Rating on CNTB: Fast-Acting Rademikibart Data Underscore Differentiation and Long-Term Respiratory Opportunity
3M ago
CNTB
Connect Biopharma Highlights Positive Rademikibart Respiratory Trial Results
PremiumCompany Announcements
Connect Biopharma Highlights Positive Rademikibart Respiratory Trial Results
3M ago
8K
CNTB
Connect Biopharma announces results from rademikibart study
PremiumThe FlyConnect Biopharma announces results from rademikibart study
3M ago
CNTB
CNTB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CNTB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
CNTB
Connect Biopharma highlights new mechanism of action data for rademikibart
Premium
The Fly
Connect Biopharma highlights new mechanism of action data for rademikibart
5M ago
CNTB
H.C. Wainwright names two best 2026 ideas in SMID-cap biopharma
PremiumThe Fly
H.C. Wainwright names two best 2026 ideas in SMID-cap biopharma
5M ago
ACHV
CNTB
Connect Biopharma announces board resignation amid U.S. transition
PremiumCompany Announcements
Connect Biopharma announces board resignation amid U.S. transition
6M ago
8K
CNTB
Connect Biopharma initiated with a Buy at Lake Street
PremiumThe Fly
Connect Biopharma initiated with a Buy at Lake Street
7M ago
CNTB
Connect Biopharma Reports Significant Loss Amid Development Efforts
PremiumCompany Announcements
Connect Biopharma Reports Significant Loss Amid Development Efforts
7M ago
CNTB
Promising Outlook for Connect Biopharma Holdings Driven by Rademikibart’s Potential and Strategic Partnerships
PremiumRatingsPromising Outlook for Connect Biopharma Holdings Driven by Rademikibart’s Potential and Strategic Partnerships
7M ago
CNTB
Buy Rating for Connect Biopharma Holdings: Rademikibart’s Market Differentiation and Safety Advantages
Premium
Ratings
Buy Rating for Connect Biopharma Holdings: Rademikibart’s Market Differentiation and Safety Advantages
7M ago
CNTB
Connect Biopharma reports Q3 EPS (31c), consensus (24c)
Premium
The Fly
Connect Biopharma reports Q3 EPS (31c), consensus (24c)
7M ago
CNTB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >